Quick answer: Hormone therapy — HRT, testosterone replacement, and men's health — is a high-value, cash-pay, recurring-revenue category with strong and growing demand. The practices that win market to a specific patient who's often been dismissed elsewhere, handle the advertising-compliance restrictions around hormones and prescriptions correctly, and build for the long patient relationship that makes the economics work. Like GLP-1, it's a category where independent practices can beat the DTC platforms by competing on real clinical care rather than convenience. This guide covers how to acquire hormone therapy patients compliantly, how to position against the telehealth giants, and how to measure a recurring-care model.
Hormone therapy has quietly become one of the strongest cash-pay opportunities in medicine. Patients are motivated, the treatment is ongoing (recurring revenue), and many arrive frustrated after being told by a previous provider that their labs were "normal" and nothing was wrong. That frustration is the marketing opening: these patients are actively looking for someone who will take them seriously.
Understand the patient (it's the whole strategy)
The typical hormone therapy patient — man or woman — has usually already tried to get help and felt dismissed. They've researched symptoms, read forums, and often self-diagnosed before they ever find you. They're informed, motivated, and skeptical of both the medical establishment that brushed them off and the sketchy operators promising miracles.
That means your marketing wins on being taken seriously. Content that acknowledges the symptoms, explains a thorough diagnostic approach, and positions your practice as the place that actually listens will out-convert any promotional message. You're not creating demand; you're meeting a patient who's already looking and giving them a reason to trust you.
Compliance: hormones and prescriptions are restricted
Advertising for hormone therapy runs into the same platform restrictions as other prescription and telehealth categories. Google and Meta limit how you can advertise prescription treatments, testosterone, and related terms. Some models require LegitScript certification to run ads at all.
As with GLP-1, the answer is to build compliantly from the start: market the practice, the providers, and patient education rather than specific treatment promises, understand the platform rules for your offering, and get certification where it's required. Organic content and authority often carry more weight here than paid, precisely because paid is so restricted — which makes SEO and AI-search visibility especially valuable in this category.
Beating the DTC platforms
Men's health and hormone therapy have a wave of DTC telehealth brands, and the same logic applies as with GLP-1: you won't out-spend them, but you can out-care them. The DTC experience is fast and impersonal. A meaningful share of hormone patients — especially those with complex situations or who want ongoing, monitored care — want a real provider relationship, proper lab work, and someone who adjusts their protocol over time.
Position your practice as the thorough, medically-supervised, relationship-driven alternative. For practices with a physical location, local presence is a real advantage. The message that works: this is real medicine with a real provider, not a questionnaire and an auto-ship.
What to build
Symptom and condition content. Patients search their symptoms — fatigue, low energy, low testosterone signs, menopause and perimenopause symptoms. Content that speaks to those symptoms and explains your diagnostic approach captures patients at the moment they're looking.
Provider authority pages. In a category full of questionable operators, credible, credentialed providers are a powerful differentiator and a strong AI-citation signal.
Education that builds trust. Honest content on how hormone therapy works, what proper monitoring looks like, what to expect, and what it costs. This separates you from both the dismissive establishment and the hype merchants.
Direct-answer FAQ content. "What are the signs of low testosterone," "is TRT safe," "how much does hormone therapy cost," "what's the difference between a clinic and an online TRT service." The questions patients ask search engines and AI, answered plainly.
The AI search opportunity
Hormone therapy patients are heavy researchers, and increasingly they research through AI — asking about symptoms, treatment options, and where to go. Because the category is full of thin, promotional, or sketchy content, a practice that publishes credible, structured, provider-backed material can stand out and get cited disproportionately. For an independent hormone practice, being surfaced by AI as the legitimate, thorough, medically-supervised option is exactly the position you want — and the DTC operators' promotional content doesn't earn that trust signal.
How to measure it
Hormone therapy is a recurring-care model, so measure cost per acquired patient against lifetime value, not cost per lead or first-visit revenue. A patient on an ongoing, monitored protocol is worth far more than a single visit, which means you can invest more to acquire the right patient — provided you're tracking to enrollment and retention.
Frequently asked questions
How do independent hormone practices compete with DTC telehealth brands?
By competing on care, not convenience. DTC is fast and impersonal; many hormone patients want thorough lab work, real monitoring, and an ongoing provider relationship. Position your practice as the legitimate, medically-supervised alternative, and lean on local presence if you have it.
Can you advertise testosterone and hormone therapy online?
It's restricted. Google and Meta limit advertising for prescription and hormone treatments, and some models require LegitScript certification. Compliant marketing focuses on the practice, providers, and education rather than treatment claims — and because paid is so restricted, organic and AI-search visibility carry extra weight.
Who is the typical hormone therapy patient?
Usually someone who's already researched their symptoms and often felt dismissed by a previous provider. They're motivated and informed but skeptical. Marketing that takes their symptoms seriously and explains a thorough diagnostic approach converts best.
How much is a hormone therapy patient worth?
Because it's ongoing, monitored care, lifetime value is well above a single visit. The number to manage is cost per acquired patient against that lifetime value, not cost per lead — recurring economics support a higher acquisition cost for the right patient.
How do I get my hormone practice to show up in AI search?
Publish credible, structured content around the symptoms patients search, with named credentialed providers and direct-answer FAQs. The category is full of thin, promotional content, so legitimate, provider-backed material stands out and gets cited when patients ask AI where to go.
Mike Funkhouser is the founder of Practice Growth Co, a healthcare marketing agency focused on patient acquisition for specialty medical practices, and a contributor to Medical Economics on AI search and patient acquisition. [Book a strategy call](/book-a-strategy-call).